Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis

Antiviral Research

Volumn 77, Issue 2, 2008, Pages 136-141

  Yang, Yong Feng ^a   Zhao, Wei ^a   Zhong, Yan Dan ^a   Yang, Yi Jun ^a   Shen, Ling ^a   Zhang, Ning ^a   Huang, Ping ^a  

^a Nanjing Second Hospital   (China)

Author keywords

Hepatitis B; Interferon; Meta analysis; Thymosin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; THYMOSIN ALPHA1; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; EMBASE; FATIGUE; FLU LIKE SYNDROME; FOLLOW UP; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INJECTION SITE DISCOMFORT; IRRITABILITY; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THYMOSIN; TREATMENT OUTCOME; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 38349056857     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.10.014     Document Type: Article

References (27)

1. Ancell C.D., Phipps J., and Young L. Thymosin alpha-1. Am. J. Health Syst. Pharm. 58 10 (2001) 879-885 (Quiz 886-888)
2. Andreone P., Cursaro C., Gramenzi A., Zavagliz C., Rezakovic I., Altomare E., Severini R., Franzone J.S., Albano O., Ideo G., Bernardi M., and Gasbarrini G. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody - and hepatitis B virus DNA - positive chronic hepatitis B. Hepatology 24 4 (1996) 774-777
3. Chan H.L., Tang J.L., Tam W., and Sung J.J. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment. Pharmacol. Ther. 15 12 (2001) 1899-1905
4. Chien R.N., Liaw Y.F., Chen T.C., Yeh C.T., and Sheen I.S. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 27 5 (1998) 1383-1387
5. Chien R.N., Lin C.Y., Yeh C.T., and Liaw Y.F. Hepatitis B virus genotype B is associated with better response to thymosin alpha1 therapy than genotype C. J. Viral Hepat. 13 12 (2006) 845-850
6. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 3 (1986) 177-188
7. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 7109 (1997) 629-634
8. Giuliani C., Napolitano G., Mastino A., Di Vincenzo S., D'Agostini C., Grelli S., Bucci I., Singer D.S., Kohn L.D., Monaco F., Garaci E., and Favalli C. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level. Eur. J. Immunol. 30 3 (2000) 778-786
9. Iino S., Toyota J., Kumada H., Kiyosawa K., Kakumu S., Sata M., Suzuki H., and Martins E.B. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. J. Viral Hepat. 12 3 (2005) 300-306
10. Juni P., Altman D.G., and Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323 7303 (2001) 42-46
11. Liaw Y.F. Therapy of chronic hepatitis B: current challenges and opportunities. J. Viral Hepat. 9 6 (2002) 393-399
12. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 2 (2007) 507-539
13. Manesis E.K., and Hadziyannis S.J. Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology 121 1 (2001) 101-109
14. Mutchnick M.G., Appelman H.D., Chung H.T., Aragona E., Gupta T.P., Cummings G.D., Waggoner J.G., Hoofnagle J.H., and Shafritz D.A. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology 14 3 (1991) 409-415
15. Mutchnick M.G., Lindsay K.L., Schiff E.R., Cummings G.D., Appelman H.D., Peleman R.R., Silva M., Roach K.C., Simmons F., Milstein S., Gordon S.C., and Ehrinpreis M.N. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study. J. Viral Hepat. 6 5 (1999) 397-403
16. Rasi G., Pierimarchi P., Sinibaldi Vallebona P., Colella F., and Garaci E. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. Int. Immunopharmacol. 3 8 (2003) 1169-1176
17. Safioleas M., Lygidakis N.J., and Manti C. Hepatitis B today. Hepatogastroenterology 54 74 (2007) 545-548
18. Serrate S.A., Schulof R.S., Leondaridis L., Goldstein A.L., and Sztein M.B. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J. Immunol. 139 7 (1987) 2338-2343
19. Sterne J.A., and Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J. Clin. Epidemiol. 54 10 (2001) 1046-1055
20. Sugahara S., Ichida T., Yamagiwa S., Ishikawa T., Uehara K., Yoshida Y., Yang X.H., Nomoto M., Watanabe H., Abo T., and Asakura H. Thymosin-alpha1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B. Hepatol. Res. 24 4 (2002) 346-354
21. Sztein M.B., Serrate S.A., and Goldstein A.L. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones. Proc. Natl. Acad. Sci. U.S.A. 83 16 (1986) 6107-6111
22. Thornton A., and Lee P. Publication bias in meta-analysis: its causes and consequences. J. Clin. Epidemiol. 53 2 (2000) 207-216
23. You J., Zhuang L., Tang B.Z., Yang W.B., Ding S.Y., Li W., Wu R.X., Zhang H.L., Zhang Y.M., Yan S.M., and Zhang L. A randomized controlled clinical trial on the treatment of thymosin a1 versus interferon-alpha in patients with hepatitis B. World J. Gastroenterol. 7 3 (2001) 411-414
24. You J., Zhuang L., Cheng H.Y., Yan S.M., Qiao Y.W., Huang J.H., Tang B.Z., Ma Y.L., Wu G.B., Qu J.Y., and Wu R.X. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in (corrected) patients with chronic hepatitis B lacking HBeAg in China (corrected). J. Chin. Med. Assoc. 68 2 (2005) 65-72
25. You J., Zhuang L., Cheng H.Y., Yan S.M., Yu L., Huang J.H., Tang B.Z., Huang M.L., Ma Y.L., Chongsuvivatwong V., Sriplung H., Geater A., Qiao Y.W., and Wu R.X. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study. World J. Gastroenterol. 12 41 (2006) 6715-6721
26. Zavaglia C., Severini R., Tinelli C., Franzone J.S., Airoldi A., Tempini S., Bettale G., and Ideo G. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig. Dis. Sci. 45 4 (2000) 690-696
27. Zhuang L., You J., Tang B.Z., Ding S.Y., Yan K.H., Peng D., Zhang Y.M., and Zhang L. Preliminary results of thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J. Gastroenterol. 7 3 (2001) 407-410